Clinical Trial Update: Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam [Phase 2]

View source ↗

Summary

Phase 2 trial update for subjects aged 18-65 with partial onset seizures already taking levetiracetam; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy Partial

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma SA | Conditions: Epilepsy, Partial | Phase 2 | Status: COMPLETED | Results posted: 2023-09-07